Poehling Capital Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Poehling Capital Management's OGN Position: Q2 2026 in Review
Poehling Capital Management sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 219,288 shares — an estimated $1.31M sold.
Poehling Capital Management first reported a position in OGN in Q2 2021 and held it in 20 quarters. The position peaked at $10.4M in Q1 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Poehling Capital Management reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
- Poehling Capital Management sold 219,288 Organon & Co shares in Q2 2026, an estimated $1.31M.
- Poehling Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 20 quarters.
- Poehling Capital Management's Organon & Co position peaked at $10.4M in Q1 2022.
- 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Poehling Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.